WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 2'1501 Infant (under 12 months) mortality rate: 342
GDP / capita (US$): 5'9961 Child (under 5 years) mortality rate: 392

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 31'447  30'976  30'500  30'020  29'541  24'849  20'462  15'940 
Births 659  663  664  663  660  565  714  575 
Surviving infants 641  644  644  643  639  535  670  532 
Pop. less than 5 years 3'184  3'197  3'186  3'181  3'159  2'856  3'217  2'437 
Pop. less than 15 years 8'798  8'690  8'580  8'497  8'439  9'260  8'322  6'493 
Female 15-49 years 8'698  8'617  8'540  8'452  8'354  6'445  4'804  3'672 

Number of reported cases

(Click for retrospective incidence data for Uzbekistan)
Diphtheria
ChartChart
  12 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  22  80  3'943 
Mumps
ChartChart
  268  2'336  3'256  2'300  3'949 
Pertussis
ChartChart
  103  69  42  62  77  713 
Polio*
ChartChart
 
Rubella
ChartChart
  454 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uzbekistan)
Vaccine year result method % card seen                                                
BCG 2005  100  MICS   96  99*  99*  99*  99*  99*  98 
DTP1 2005  99  MICS   96  99*  99  99*  99*  99*  97 
DTP4          99*  99  99* 
DTP3 2005  93  MICS   96  99*  99  99*  99  99  99 
HepB_BD          99*  99*  99*  99*  99* 
IPV1         
HepB3 2005  90  MICS   96  99*  99  99*  99  99 
Hib3          99*  99  99*  99  99 
JapEnc         
MCV1          99*  99*  99*  97  99*  99 
MenA         
MCV2          99*  99*  99*  99*  99*  99 
PCV1          99*  99* 
PCV2          99*  99* 
PCV3         
Pol3 2005  90  MICS   96  99*  99*  99*  99  99*  99 
Rota1          99*  97  99* 
RotaC          99*  95  99* 
RCV1          99*  99*  99*  97  99* 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uzbekistan)
BCG
ChartChart
  99  99  99  99  99  98 
DTP1
ChartChart
  99  99  99  99  99  99 
DTP3
ChartChart
  99  99  99  99  99  99 
HepB3
ChartChart
  99  99  99  99  99 
HepB_BD
ChartChart
  99  99  99  99  99 
Hib3
ChartChart
  99  99  99  99  99 
IPV1
 
MCV1
ChartChart
  99  99  99  97  99  99 
MCV2
ChartChart
  99  99  99  99  99  98 
PCV3
ChartChart
  99 
Pol3
ChartChart
  99  99  99  99  99  99 
RCV1
ChartChart
  99  99  99  97  99 
RotaC
ChartChart
  99  95  52 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 196  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3 days; Yes
DTwP 16 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB_Pediatric birth; Yes
Influenza_Adult Yes elderly and health care workers, Haj and travelers
MMR 1, 6 years; Yes
OPV 2, 3, 4, 16 months; 7 years; Yes
Pneumo_conj 2, 3, 12 months; Yes
Rotavirus 2, 3 months; Yes
Td 7, 16 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2015-2020  2015-2018  2010-2015  2010-2015  2010-2015  2010-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 196  196  196  195  194  195   

System performance

Total Nº districts in country number 196  196  196  195  196  195  199 
Nº districts with DTP3 coverage >=80% number 196  196  196  195  196    199 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100    100 
Nº districts with measles (MCV1) coverage >=95% number 196  196  196  195  196    199 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100    100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 52    80  72      11 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.